Prometheus Biosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Prometheus Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q1 2023.
  • Prometheus Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2023 was -$40.9M, a 27.5% decline year-over-year.
  • Prometheus Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2023 was -$151M, a 39% decline year-over-year.
  • Prometheus Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$142M, a 57.2% decline from 2021.
  • Prometheus Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$90.2M, a 143% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$151M -$40.9M -$8.81M -27.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 -$142M -$38.8M -$8.85M -29.6% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-28
Q3 2022 -$133M -$37.3M -$9.94M -36.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 -$123M -$33.6M -$14.6M -77.1% Apr 1, 2022 Jun 30, 2022 10-Q 2022-11-09
Q1 2022 -$108M -$32.1M -$18.1M -130% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$90.2M -$29.9M -$21.3M -247% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$68.9M -$27.3M -$20.4M -293% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$48.5M -$19M -$10.6M -125% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 -$38M -$13.9M -$817K -6.22% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 -$37.1M -$8.62M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$6.95M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$8.44M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$13.1M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.